S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX
S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX is a paper indexed in PICO Portal from OpenAlex.
How many citations does S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX have?
S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX has 1 citations in the OpenAlex counts PICO Portal stores.
When was S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX published?
S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX has 2025 year in the PICO Portal index.
What is the open-access status of S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX?
S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX has closed oa status in the PICO Portal index.
What is the DOI of S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX?
The DOI for S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX is on the source record.
What is the OpenAlex record for S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX?
The OpenAlex for S3024 Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX is on the source record.